Jupiter Neurosciences, Inc. (NASDAQ:JUNS) Financings
Financings
| Raise | Date |
|---|---|
| Convertible Promissory Notes Terms changed: US$6M Buyers: Yorkville Advisors Global, LP (affiliate) ($6 million pre-paid advance, $4 million funded at signing); YA II PN, Ltd. Use of proceeds: Phase 2 Parkinson's trial of JOTROL, Nugevia direct-to-consumer marketing and sales growth, working capital and general corporate purposes | Feb 23, 2026 |
| Common stock under standby equity purchase agreement Announced: up to US$14M Buyers: Yorkville Advisors Global, LP (affiliate) (up to $14 million of Common Stock over 24 months) Use of proceeds: Phase 2 Parkinson's trial of JOTROL, Nugevia direct-to-consumer marketing and sales growth, working capital and general corporate purposes | Oct 27, 2025 |